CLINICAL_TRIALS
trial_result
· 2013-12-10
Clinical Trial Update: Safety and Efficacy Evaluation of Topical AL-60371 Otic Suspension, 0.3% in the Treatment of Acute Otitis Externa [Phase 3]
Summary
A Phase 3 study evaluated the safety and efficacy of AL-60371 0.3% topical otic suspension for acute otitis externa, with results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alcon Research | Conditions: Acute Otitis Externa | Phase 3 | Status: COMPLETED | Results posted: 2013-12-10